NYITCOM Physician: Diabetes Patients Should Heed FDA Warning
In late February, the Food and Drug Administration (FDA) warned diabetes patients not to use smartwatches or smart rings to measure their blood glucose levels. Following the FDA’s alert, obesity medicine expert Eleanor Yusupov, D.O., assistant professor at the College of Osteopathic Medicine, shares valuable insight for these patients.
While many of these devices are marketed as noninvasive solutions, allowing users to measure their blood glucose levels without pricking the skin, Yusupov notes that the FDA has not authorized, cleared, or approved any noninvasive smartwatch or smart ring to measure glucose. What’s more, relying on these devices could have life-threatening consequences.
“It is very concerning that patients may be misled by the marketing claims and rely on smartwatches or smart rings that do not accurately measure blood glucose,” says Yusupov. “Using devices that are not approved by the FDA may lead to serious health consequences. If left untreated, very high or very low blood sugar can be extremely dangerous and cause severe complications, even coma and death.”
Instead, she advises patients with diabetes to use continuous glucose monitoring (CGM) devices approved by the FDA and provide accurate information about how a patient’s body reacts to diabetes medications and foods eaten. Depending on the specific CGM device used, physicians may program it to set off an alarm when blood sugar is dangerously high or low.
“Your doctor can recommend and prescribe a continuous glucose monitoring device that automatically checks your sugar and sends the result to your smartphone or a smartwatch. Most patients prefer this modern technology, which uses a tiny sensor placed in the arm, to traditional glucose meters that require pricking your finger,” she says.
Yusupov adds that, for some patients, monitoring blood glucose can be done at regularly scheduled doctor’s visits and does not need to be done daily. However, people using insulin or multiple diabetes medications are advised to monitor their blood sugar daily or several times a day to avoid dangerously high or low readings.
More than 38 million Americans are estimated to have diabetes, with 8.5 million believed to be living with the condition undiagnosed. In addition, 38 percent of the United States adult population is estimated to have prediabetes, a serious condition that increases the risk of developing type 2 diabetes, heart disease, and stroke.
Learn more about diabetes signs and symptoms.
More News
The Strength of the Hispanic Woman
For Hispanic Heritage Month, Chantel Diaz (B.F.A. ’13, M.A. ’15) reflects on the role of women in Hispanic culture and how it has shaped who she is today.
Faculty Profile: Rosemary Gallagher
Associate Professor Rosemary Gallagher, Ph.D., D.P.T., discusses her work with Parkinson’s patients, involvement with New York Tech’s Rock Steady Boxing program, and other projects.
Recognizing NYITCOM Alumni and Friends
On May 1, NYITCOM celebrated several renowned graduates and a dedicated community partner at the medical school’s annual Alumni Awards Dinner.
Faculty Profile: Athina Papadopoulou
Assistant Professor Athina Papadopoulou, Ph.D., believes smart clothes are in our future and may have a significant impact on our daily style as well as improve the lives of people with disabilities.
400-Year-Old Painting Offers Insights for Today’s Marketers
An eye movement study led by the College of Arts and Sciences’ Robert G. Alexander, Ph.D., suggests that techniques used in a Baroque-era painting could help today’s marketers catch the attention of modern consumers.
Renovated Engineering Labs Unveiled on New York City Campus
The College of Engineering and Computing Sciences held its grand opening of newly renovated laboratory spaces, poised to provide students with a state-of-the-art research experience.